Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]".
Krolewiecki A, Lifschitz A, Moragas M, Travacio M, Valentini R, Alonso DF, Solari R, Tinelli MA, Cimino RO, Álvarez L, Fleitas PE, Ceballos L, Golemba M, Fernández F, de Oliveira DF, Astudillo G, Baeck I, Farina J, Cardama GA, Mangano A, Spitzer E, Gold S, Lanusse C.
Krolewiecki A, et al. Among authors: cimino ro.
EClinicalMedicine. 2021 Sep;39:101119. doi: 10.1016/j.eclinm.2021.101119. Epub 2021 Aug 26.
EClinicalMedicine. 2021.
PMID: 34462733
Free PMC article.